Literature DB >> 25103301

Global causes of maternal death: a WHO systematic analysis.

Lale Say1, Doris Chou2, Alison Gemmill3, Özge Tunçalp2, Ann-Beth Moller2, Jane Daniels4, A Metin Gülmezoglu2, Marleen Temmerman2, Leontine Alkema5.   

Abstract

BACKGROUND: Data for the causes of maternal deaths are needed to inform policies to improve maternal health. We developed and analysed global, regional, and subregional estimates of the causes of maternal death during 2003-09, with a novel method, updating the previous WHO systematic review.
METHODS: We searched specialised and general bibliographic databases for articles published between between Jan 1, 2003, and Dec 31, 2012, for research data, with no language restrictions, and the WHO mortality database for vital registration data. On the basis of prespecified inclusion criteria, we analysed causes of maternal death from datasets. We aggregated country level estimates to report estimates of causes of death by Millennium Development Goal regions and worldwide, for main and subcauses of death categories with a Bayesian hierarchical model.
FINDINGS: We identified 23 eligible studies (published 2003-12). We included 417 datasets from 115 countries comprising 60 799 deaths in the analysis. About 73% (1 771 000 of 2 443 000) of all maternal deaths between 2003 and 2009 were due to direct obstetric causes and deaths due to indirect causes accounted for 27·5% (672 000, 95% UI 19·7-37·5) of all deaths. Haemorrhage accounted for 27·1% (661 000, 19·9-36·2), hypertensive disorders 14·0% (343 000, 11·1-17·4), and sepsis 10·7% (261 000, 5·9-18·6) of maternal deaths. The rest of deaths were due to abortion (7·9% [193 000], 4·7-13·2), embolism (3·2% [78 000], 1·8-5·5), and all other direct causes of death (9·6% [235 000], 6·5-14·3). Regional estimates varied substantially.
INTERPRETATION: Between 2003 and 2009, haemorrhage, hypertensive disorders, and sepsis were responsible for more than half of maternal deaths worldwide. More than a quarter of deaths were attributable to indirect causes. These analyses should inform the prioritisation of health policies, programmes, and funding to reduce maternal deaths at regional and global levels. Further efforts are needed to improve the availability and quality of data related to maternal mortality.
© 2014 World Health Organization; licensee Elsevier. This is an Open Access article published without any waiver of WHO's privileges and immunities under international law, convention, or agreement. This article should not be reproduced for use in association with the promotion of commercial products, services, or any legal entity. There should be no suggestion that WHO endorses any specific organisation or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.

Entities:  

Mesh:

Year:  2014        PMID: 25103301     DOI: 10.1016/S2214-109X(14)70227-X

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


  1200 in total

1.  Amniotic Fluid Embolism (AFE) in China: Are maternal mortality and morbidity preventable?

Authors:  Xiuting Mo; Aihua Feng; Xiaoyan Liu; Ruoyan Gai Tobe
Journal:  Intractable Rare Dis Res       Date:  2014-08

2.  Combination Antiretroviral Therapy and Hypertensive Disorders of Pregnancy.

Authors:  Michele K Saums; Caroline C King; Jenna C Adams; Anandi N Sheth; Martina L Badell; Marisa Young; Lynn M Yee; Ellen G Chadwick; Denise J Jamieson; Lisa B Haddad
Journal:  Obstet Gynecol       Date:  2019-12       Impact factor: 7.661

3.  Determinants of practice of preconception care among women of reproductive age group in southern Ethiopia, 2020: content analysis.

Authors:  Aklilu Habte; Samuel Dessu; Dereje Haile
Journal:  Reprod Health       Date:  2021-05-21       Impact factor: 3.223

4.  A Comparison of 2-Methoxyestradiol Value in Women with Severe Preeclampsia Versus Normotensive Pregnancy.

Authors:  John Wantania; Ahsanuddin Attamimi; Rukmono Siswishanto
Journal:  J Clin Diagn Res       Date:  2017-03-01

Review 5.  Preeclampsia and Cerebrovascular Disease.

Authors:  Eliza C Miller
Journal:  Hypertension       Date:  2019-05-06       Impact factor: 10.190

6.  VEGF-A and VEGFR1 SNPs associate with preeclampsia in a Philippine population.

Authors:  Melissa D Amosco; Van Anthony M Villar; Justin Michael A Naniong; Lara Marie G David-Bustamante; Pedro A Jose; Cynthia P Palmes-Saloma
Journal:  Clin Exp Hypertens       Date:  2016-09-26       Impact factor: 1.749

Review 7.  Heightened susceptibility: A review of how pregnancy and chemical exposures influence maternal health.

Authors:  Julia Varshavsky; Anna Smith; Aolin Wang; Elizabeth Hom; Monika Izano; Hongtai Huang; Amy Padula; Tracey J Woodruff
Journal:  Reprod Toxicol       Date:  2019-05-02       Impact factor: 3.143

8.  Pregnancy-related and maternal deaths in Hamburg, Germany: an autopsy study from 1984 - 2018.

Authors:  Carolin Edler; Jan Peter Sperhake; Klaus Püschel; Ann Sophie Schröder
Journal:  Forensic Sci Med Pathol       Date:  2019-08-01       Impact factor: 2.007

Review 9.  Investigating Maternal Brain Alterations in Preeclampsia: the Need for a Multidisciplinary Effort.

Authors:  Lina Bergman; Pablo Torres-Vergara; Jeffrey Penny; Johan Wikström; Maria Nelander; Jose Leon; Mary Tolcher; James M Roberts; Anna-Karin Wikström; Carlos Escudero
Journal:  Curr Hypertens Rep       Date:  2019-08-02       Impact factor: 5.369

10.  Cost-effectiveness of two interventions for the prevention of postpartum hemorrhage in Senegal.

Authors:  Michael Vlassoff; Alioune Diallo; Jesse Philbin; Kathryn Kost; Akin Bankole
Journal:  Int J Gynaecol Obstet       Date:  2016-02-12       Impact factor: 3.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.